Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TPBG encodes a leucine-rich transmembrane glycoprotein that may be involved in cell adhesion. Additionally we are shipping TPBG Proteins (11) and TPBG Kits (5) and many more products for this protein.
Showing 10 out of 57 products:
Mouse (Murine) Polyclonal TPBG Primary Antibody for FACS, ICC - ABIN4900172
Takahashi, Ogawa, Yoshihara, Asahina, Kinoshita, Kitano, Kitsuki, Tatsumi, Okuda, Tatsumi, Wanaka, Hirai, Stern, Tsuboi: A Subtype of Olfactory Bulb Interneurons Is Required for Odor Detection and Discrimination Behaviors. in The Journal of neuroscience : the official journal of the Society for Neuroscience 2016
Show all 2 references for ABIN4900172
In conclusion, the present study provided evidence that TPBG is involved in PDAC metastasis, and that TPBG and its associated signaling pathways may be a suitable target for pancreatic ductal adenocarcinoma therapy.
5T4 expression is mechanistically associated with the directional movement of cells through epithelial mesenchymal transition, facilitation of CXCL12 (show CXCL12 Antibodies)/CXCR4 (show CXCR4 Antibodies) chemotaxis, blocking of canonical Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) while favouring non-canonical pathway signalling
Tyrosine 325 plus the leucine-rich repeat 1 surface centered on a second exposed aromatic residue, phenylalanine 97, are essential for inhibition of Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling.
The surface expression of 5T4 marks the use of the CXCR4 (show CXCR4 Antibodies) rather than the CXCR7 (show CXCR7 Antibodies) receptor, with distinct consequences for CXCL12 (show CXCL12 Antibodies) exposure.
5T4 is a potential new antigen for targeted therapies such as immunotherapy in MPM, as it is overexpressed on mesothelioma cells and recognised by 5T4-specific cytotoxic T-cells.
Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen
Results sugest that 5T4 is a transient marker of human embryonic stem cell differentiation & that 5T4 phenotype, colony seeding density and culture conditions influence the maintenance of pluripotent hES (show RRBP1 Antibodies) cells and their differentiation to neural lineages.
there is a repertoire of CD8 T cell recognition of 5T4 in normal human donors and some candidate HLA-A*0201 epitopes have been identified
the mRNA expression of trophoblast glycoprotein is up-regulated in cells circulating within blood from women with preeclampsia.
5T4-based cancer vaccine: cytotoxic T lymphocyte epitopes identified in Trovax-vaccinated colorectal cancer patients
5T4 overexpression in newborn olfactory bulb interneurons facilitates their dendritic arborization even under a sensory input-deprived condition.
molecular interaction of 5T4 and CXCR4 (show CXCR4 Antibodies) occurring at the cell surface which directly facilitates the biological response to CXCL12 (show CXCL12 Antibodies)
Spry4 (show SPRY4 Antibodies) and Tpbg/5T4 were detected in Kit-immunoreactive cells only in Kit(K641E), but not in Kit(WT/WT) animals.
5T4 glycoprotein expression is associated with early differentiative events of embryonic stem cells
A limited expression profile of 5T4 may contribute to the migration of actively cycling, undifferentiated epithelial progenitor cells during embryogenesis
Because 5T4 is known to interact with actin cytoskeleton, these observations suggest that 5T4 is involved in the formation or maintenance of strata-specific dendritic ramification or synaptic connection of subsets of local interneurons.
E-cadherin (show CDH1 Antibodies) protein stabilizes cortical actin cytoskeletal arrangement in embryonic stem cells, and this can prevent cell surface localization of the promigratory 5T4 antigen.
This gene encodes a leucine-rich transmembrane glycoprotein that may be involved in cell adhesion. The encoded protein is an oncofetal antigen that is specific to trophoblast cells. In adults this protein is highly expressed in many tumor cells and is associated with poor clinical outcome in numerous cancers. Alternate splicing in the 5' UTR results in multiple transcript variants that encode the same protein.
, 5T4 oncofetal trophoblast glycoprotein
, Trophoblast glycoprotein
, trophoblast glycoprotein-like
, 5T4 oncofetal antigen
, 5T4 oncotrophoblast glycoprotein